chrisvoncsefalvay/vaers-outcomes huggingface dataset:
her arm feels like someone punch it; mild headaches; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program. The reporter is the patient.  A 63 year-old female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (DOSE 1, SINGLE), administration date: 14Mar2021, for Covid 19 Immunization. The following information was reported: LIMB DISCOMFORT (non-serious), outcome "unknown", described as "her arm feels like someone punch it"; HEADACHE (non-serious), outcome "unknown", described as "mild headaches". Therapeutic measures were taken as a result of limb discomfort, headache.  Additional information: She explained despite her appointment, she waited over 5 hours to get the shot. She specified there was a waiting line; and the pharmacist encouraged her to go home after vaccination instead of being monitored as recommended stating it would be more dangerous to stay in the store with over 30 people. The patient got her first dose a week ago 14Mar2021. However, the facility where she visited scheduled her four weeks later instead of three. She was asked to return on 11Apr2021. According to her, perhaps the reason why she was scheduled four weeks later is because the facility administers the vaccines. Pfizer-BioNTech and Moderna. She wants to know the efficacy of the vaccine when received four weeks instead of three after the first dose. She explained she received the second dose of the Pfizer-BioNTech COVID-19 vaccine yesterday. She added she spoke with somebody from the CDC who confirmed that the vaccine would maintain its efficacy, when the second dose is given 28 days after the first. She mentioned she's happy she's experiencing side effects post vaccination as it indicates that she is building a response to it. She specified her arm feels like someone punch it and she have mild headaches. She added she took Tylenol and has been drinking a lot of water.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
An MA reported that 75 year old male received a dose of Pnu-Imune 23 vaccine on 6/7/01. The next day, he developed an injection site reaction. He was seen in the ER and was prescribed antibiotics for cellulitis. The pt recovered. This is 1 of 3 pts from this facility who experienced this event following receipt of Pnu-Imune 23, lot 468147. (See HQ 2484325JUN2001 and HQ 3428818JUL2001).
Pt felt very anxious.  Pain in axilla of arm receiving vaccine.  Chills. Anxiety and chill resolved in 24 hours.  Axilla still painful.
On 03/01/2006, pruritus and urticaria on arms, legs, trunk, back, scalp.  On 03/04/2006 went to doctor, given prescription steroid and anti-histamine.
This spontaneous report as received from a female registered pharmacist of an unknown age with dry eyes reporting on herself. On 12-APR-2013, the pharmacist was administering a dose of ZOSTAVAX (Lot # not reported) to a patient and she splashed the ZOSTAVAX in her right eye. The pharmacist immediately flushed her eye with saline but continued to experience dry eye, eye pressure and felt like something was in her eye. The pharmacist used tobramycin eye drops for a couple days and was now using artificial tears. At the time of the report, the patient's outcome was not recovered. Additional information has been requested.
Information has been received from a Nurse Practitioner concerning an approximately 9 year old female who was vaccinated with the first dose of Gardasil.  Subsequently the patient experienced nose bleeds that started about two hours after the vaccine was administered and has continued every day.  As of 03-AUG-2007, the patient had not recovered.  Medical attention was sought and a CBC was performed (results not reported). Additional information has been requested.
Information has been received from a nurse practitioner referring to 4 year old male patient with blueberries allergy. The patient had no illness at time of vaccination. Concomitant therapies included (Oka/Merck) VARIVAX and KINRIX. On 28-APR-2016 at 16:29, the patient was vaccinated with (wistar ra 27-3) M-M-R II lot # L007577 does 2, subcutaneously in the left thigh. The vaccine was properly stored at 53.2 F for 9 hours and 25 minutes. There were no previous temperature excursions. Digital data logger was involved. No adverse effect was reported. This is one of several reports received rom the same reporter. Additional information has been requested.
awful thirsty; throat is dry/throat is a little bit dry; hot flashes; This is a spontaneous report from a contactable consumer (patient). A 80-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number: EN6206), dose 1 via an unspecified route of administration, administered on Arm Left on 07Mar2021 09:30 as DOSE 1, SINGLE for covid-19 immunisation (at the age 80 years). The patient medical history and concomitant medications were not reported. The patient experienced hot flashes on 07Mar2021, awful thirsty and throat is dry on an unspecified date. This consumer was administered the first dose of Pfizer COVID-19 Vaccine 07Mar2021. She reported that she did have a couple of small effects from the vaccine that she did not see on the list that she has for the vaccine. She clarified that those couple of small effects were 2 hot flashes that occurred 07Mar2021; and she mentioned her throat is a little bit dry. She did not think the throat being a little bit dry had anything to do with the vaccine, it could just be because the air where she was dry. She asked about these events relative to the vaccine and how long after having the vaccine does it took to develop antibodies. About Hot flashes it was reported as first hot flash occurred about 20:00, second hot flash occurred about 22:00. She should not be having hot flashes at 80 years old. She has not had hot flashes in years before this. She was fine now. This event almost had to be from the vaccine. Lot number: She believed this to be EN6206, although the number 2 could be the letter Z, but she though it was number 2. Second dose was scheduled for 27Mar2021. The patient underwent lab tests and procedures which included sars-cov-2 antibody test: negative on 10Feb2021. The patient had no physician's office, emergency room visit or hospitalization related to these events. The clinical outcome of the event hot flashes was recovered on 07Mar2021 and for the events awful thirsty and throat is dry, outcome was unknown.  No follow-up attempts are possible. No further information is expected.
12/28 approximately 30 minutes after vaccine - face very red.  Neck and upper chest itching.  Itching resolved after about 30-40 minutes. Redness resolved after a few hours.  On 1/1 , swollen lymph node in neck, painful. On 1/5 , painful lymph nodes in neck, across clavicle area to armpit. Today, 1/8, lymph nodes still swollen and painful.
Hard nodule under skin that started day after vaccine, minimal pain, no erythema, no drainage, mild swelling around site.  Home care of warm compresses, massage were recommended after evaluation in clinic
This spontaneous report as received from a physician regarding a patient of unknown age and gender. Medical history and concurrent conditions were not reported. On 16-JUN-2015, the patient received improperly stored VARIVAX (Merck) (lot#K010440, expiry date: 22-JUL-2016, dosing details were not specified) which was stored at 23 Fahrenheit for 27:00 hours. There was not concomitant medication reported. No adverse effects was reported and no product quality complaint involved. This is one of several reports received from the same reporter. Additional information has been requested.
osteoarthritis pain increased, orthodontic pain (pressure from chewing, temperature sensitive), lymph node very swollen under infected arm (extremely painful, node was too swollen to wear a bra for a full week. node was similar in size to my breast- I am a D cup), lack of appetite. artritis and dental pain and fatigue started within 2 hours, node was noticed by 6 pm, swelling increased through the weekend, started to subside wednesday 3/9/22, but swelling was not gone for at least 4 days after. appetite still minimal. Allergist strongly recommended reporting reactions, she noted for future vaccinations for covid, I should be closely monitored
This spontaneous report was received from a nurse practitioner regarding an unknown number of patients of unknown ages and genders. The patients' pertinent medical history, drug reactions/allergies and concomitant medications were not reported. On unknown dates, the patients were vaccinated with unspecified number of improperly stored doses of M-M-R II (rHA) (lot# L040960, batch/lot# M008588, expiry dates and dosing details not known) for prophylaxis. The lot# L040960 was stored at 9.6 Celsius(C) for 46 hours and batch/lot# M008588 was stored at 9.6 Celsius(C) for 19 hours. No adverse effects were reported. There was no product quality complaint (PQC) involved. Lot number M008588 has been verified to be a valid lot number for M-M-R II. As of 02-DEC-2016, all telephone attempts to obtain follow-up information have been unsuccessful. Additional information has been requested.; Sender's Comments: MERCK 1610USA001709:Mfr number.
After the second shot I woke up the next day sick with flu like symptoms that lasted for 7 days. After that I have never recovered from the fatigue.
Vomiting multiple times, diarrhea with mucus multiple times 24 hrs after rotavirus vaccine. Got admitted with dehydration for 2 days.  11/19/08-records received for DOS-11/15-11/16/08-presented with C/O 4-5 day history of vomiting and diarrhea.
BOUT OF BELL'S PALSY; This spontaneous report received from a patient via social media through a company representative concerned a patient of unspecified age, sex, race and ethnicity. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) 1 total, dose (dose number in series:1), start therapy date were not reported for prophylactic vaccination. The batch number was not reported. The company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported.  On an unspecified date, the patient experienced bout of bell's palsy. The consumer reported as "I had a bout of Bell's palsy after being vaccinated ". The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of bout of bell's palsy was not reported. This report was serious (Other Medically Important Condition).; Sender's Comments: V0- 20211258411-Covid-19 vaccine ad26.cov2.s-Bout of bell's palsy . This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).
The evening after the shot (yesterday, Saturday), I had a very sore/tender arm from the injection site (more than the flu shot), and I felt a little bit chilled. The next day (today, Sunday), my arm was very sore, I felt more chilled and shivery, body aches, very fatigued, and all I wanted to do was sleep. I had a headache that grew in intensity until it was pounding, and I felt nauseated. Eventually, I vomited. After vomiting, I slept for another 1.5 hours or so and when I woke up, I felt a bit better, even the injection site didn't feel as painful. I took two ibuprofin. My stomach had settled and I was able to have some hot tea and eat a bit of food. I remained very tired and fatigued for the rest of the day, but no longer felt sick or nauseated. It took about 24 hours to get through the side effects.
This is a spontaneous report received from a contactable consumer (patient). A patient (no qualifiers provided) received the 2nd dose of BNT162B2 (Pfizer-BioNTech COVID-19 vaccine, batch/lot# unknown), single dose, for COVID-19 immunisation. The patient's medical history and concomitant medications not reported. Vaccination history included the 1st dose of BNT162B2 (Pfizer-BioNTech COVID-19 vaccine, batch/lot# not provided), for COVID-19 immunisation. The patient experienced pain in extremity/peripheral swelling/arm is swollen just a little/little pain in that arm/the other arm strangely a little pain/arm is very, very sore, with outcome of unknown. Additional Information: Yesterday (unspecified date) about 1 o'clock, patient had the second shot of the vaccine. After the first shot, patient did not feel pain, and experienced nothing. For the second shot, they got little pain in that arm and the other arm strangely also had a little pain. The person who admitted the patient at the time of the shot, mentioned what to take, but patient thought of not needing to take anything because there was no problem with the first shot. Since the second shot, their arm was very, very sore. Also, it's swollen just a little. Patient wanted to know what type of treatment to get. The person advised Benadryl (diphenhydramine), Tylenol (acetaminophen) or Advil (ibuprofen) but ignored it because the patient was basing it on the first experience. No follow-up attempts possible. Information about batch/lot number cannot be obtained. No further information expected.
Daughter was given two injections of GARDASIL and shortly after was diagnosed with auto immune disease MG which means grave muscle.  She has had surgery to remove thymus but still has not recovered.  She can not do sports, speak clearly or swallow well.  May or may not recover.  She never had any prior health problems.  8/27/09 Hospital records received DOS 2/23/09 to 2/28/09. Assessment: Myasthenia gravis, post total thymectomy. Patient c/o of trouble with swallowing and speech articulation unrelieved by tonsillectomy. Weight loss. Ptosis. Generalized weakness. Dx'd with myasthenia gravis. Plasmapheresis. Presents for thymectomy to alleviate symptoms. Urinary tract infection.  ICD-9 Codes: 358.00 Myesthenia Gravis, 599.0 Urinary Tract Infection, 425.3 Other Left Bundle Branch Block, 285.9 Anemia unspecified. Follow-up: Sept 2008 - tongue swelling, hypernasal speech. Oct 2008- tonsillectomy. Dec 2008- Drooping lower lip / lack of gag reflex disarthric speech.
10 hours after vaccine administered, body pain, lowered mood, and fever into the night. Hallucinations, fever dreams, night sweats, and possible seizure (unsure, facial twitching was present during suspected hallucination/fever dreaming).
Red rash on one side of the chest. Some red spots on the right side of the neck. It is mildly itchy.
GBS; This case was reported by a physician via sales rep and described the occurrence of guillain barre syndrome in a 78-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, 72 hrs after receiving Shingrix, the patient experienced guillain barre syndrome (serious criteria GSK medically significant). On an unknown date, the outcome of the guillain barre syndrome was unknown.   It was unknown if the reporter considered the guillain barre syndrome to be related to Shingrix.  Additional details were provided as follows: After receiving Shingrix, the patient development guillain barre syndrome. There was no prior illness.
She had the usual crying, fussiness and soreness.  But it was more.  The side of her face drooped.  She went from being very alert (almost completely rolling over at 2 wks of age) to being dulled.  She had been so interested in figuring out patterns on wallpaper that she wasn't interested in nursing.  After the immunization, she started acting ... slower.  I did tell my doctor, but he doesn't believe any of the immunizations are dangerous.  He wrote, "Parent refused immunizations" thereafter.  I did more research and will not immunize again.  I cannot in good conscience ever immunize again and have stated to my doctor that I don't want my children immunized further due to religious beliefs of not harming our bodies.  Doc wasn't happy.  I didn't report it further as I was unaware of this database.  The dates and times are to the best of my memory.  Her birth weight was 7# 4oz.
L delt slightly swollen, red and warm. Tdap and MENVEO given IM 3 days prior. Advised cool compress. Noted in chart and RTC if not  improved x2-3d.
Pain / soreness at injection site lasting 2-3 days. Headache beginning around 12-15 hours after shot, lasting about 2-3 days. Stomach ache and nausea beginning around 18 hrs after shot and lasted 10-12 hrs. Fever up to 101.8 beginning around 18 hours after shot and lasting around 6-8 hours (came down w/ medication).
This spontaneous report as received from a physician refers to an unspecified number of patients of unknown age and gender. The patients' medical history, concurrent conditions and concomitant medications were not reported. On unknown dates, the patients were vaccinated with the improperly stored (above 46F but below 77F with a maximum temperature of 50F for 3 hours 15 minutes plus a second excursion between 32F and 36F, to 35 F for 3.5 minutes) doses of VAQTA (lot # M036459, expiration date 18-JAN-2018; dose and route of administration were not reported) for prophylaxis. No adverse effects and no previous excursion were reported. The call was made because of a data logger. This is one of two reports received from the same reporter. Additional information is not expected as the reporter did not wish to be contacted. Sender's Comments: US-009507513-1702USA003970.
PATIENT PRESENTED FOR IMMUNIZATION AND REVIEWED ALLERGY LISTS. INQUIRED AND PATIENT STATED SHE HAD NO PREVIOUS REACTION TO VACCINATIONS. NO ALLERGY EXCEPT TO HAND SANITIZER (LATER SAID COULD EAT ORANGES BUT NOT DRINK ORANGE JUICE). ADMINISTERED VACCINE (AND ALSO WAS PRESENT FOR A FRIENDS VACCINE SO I  OBSERVED HER FOR 15 MINUTES IN PERSON WITH NO REACTION AND ASKEDAFTER 15 MINUTES IF SHE WAS STILL  OK AND ANSWERED YES WAS OK). SHE WAITED FOR ABOUT ANOTHER 10 TO 15 MINUTES AND REPORTED THAT WAS ITCHING ACROSS BACK AND LEGS. NO SWELLING IN FACE WAS EVIDENT AND CONFIRMED BY FRIEND. NO SHORTNESS OF BREATH OR DIZZINESS.  TECH WERE NOTIFIED OF ALLERGIC REACTION AND GIVEN REQUESTS: THEY CALLED PHARMACY MANAGER. I OFFERED AND GAVE 50MG DIPHENHYDRAMINE LIQUID (12.5MG/5ML=20ML). i OFFERED TO CALL FOR AMBULANCE AND PATIENT DECLINED. NO EPINEPHRINE WAS ADMINISTERED OR APPROPRIATE BASED WITH PRESENT SYMPTOMS. I RECOMMENDED TO THE PATIENT TO BE EVALUATED AT HOSPITAL EMERGENCY DEPARTMENT BUT PATIENT DECLINED. PATIENT WAITED AND PRESENTED TO ME AT 8:25 TO 8:30PM AND RELAYED WAS FEELING OK ( TWO THUMBS UP) AND LEFT STORE WITH FRIEND.
I tested positive for covid on May 24, 2022. Symptons: sore throat, fever, headache, cold symptons. I was treated with Paxlovid for 5 days. This morning I took my last dose. I was taking 2 pills in the morning and 2 in the evening. Currently, I just sound a bit nasal but that's it. I had a virtual visit with a physician who prescribed the Paxlovid.
About two hours after injection, experienced nausea. Four hours after injection, experienced extreme fatigue and a slight headache. Experienced overall slight fatigue for 4 days. On the fourth day after shot (4/14/21), experienced a full body "buzzing" sensation and also nausea.
A few minutes after the immunization patient flushed and was feeling faint.  She then started having chest pain.  911 was called and paramedics arrived within 2 minutes.  After approximately 10 minutes her symptoms resolved and she stated she felt fine.  Paramedics convinced her to go to the hospital.
pt recvd vax;apap given q/ 4 hrs;fever;rt leg had redness & lump at site;began screaming,crying for 20 mins;inconsolable w/ limpness & paleness;14oct pt fussy only; mom called rn 21nov94 to report;
pt recv vax 30JUL96 & 31JUL96 pt devel a sz;pt went to ER & was released the same noc;
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a contactable reporter(s) (Physician). The reporter is the patient.  A 56-year-old male patient received BNT162b2 (BNT162B2), on 06Jun2022 at 13:00 as dose 4 (booster), single (Lot number: 30155BA) at the age of 55 years, in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history was not reported. There were no concomitant medications. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 2022, outcome "not recovered" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive, notes: I got COVID again. Therapeutic measures were taken as a result of drug ineffective, covid-19. Clinical course: Patient received treatment as Paxlovid drug from 31Jul2022 to 04Aug2022 (Lot number: XV0001) for COVID-19. Other medication in 2 weeks was reported as no. No Known allergies. Other medical history was reported as no.; Sender's Comments: Based on the known safety profile of the vaccine  BNT162b2, a causal relation between the reported events Covid-19, Drug ineffective and the administration of the vaccine cannot be excluded.
Patient was seated in waiting area after vaccination. Patient seemed to be in obvious distress while being in and out of consciousness. The pharmacist was able to get patient safely to the ground, elevate his feet, and apply a cold compress. When consciousness was regained, he was able to drink water and eat some apple slices within about 10 minutes of initial incident. Patient was kept for additional observations and was able to verbally attest to feeling stable before leaving.
Hives, progress to welts, progress lower extremities inflammation, progress facial swelling, including eyes, lips tongue, to eventually include torso, face and limbs.  11/28/06 Received medical records from hospital which reveal patient admitted 10/29-11/03/06.  Rash had developed day after flu shot & progressed to severe itching & SOB.  Seen in ER, treated w/steroids & d/c to home on oral steroids.  Continued to worsen & returned to hospital within 24 hours & ws admitted.  Treated with IV steroids, Benadryl & epi & rash & swelling completely resolved.  She was d/c to home to be followed by allergist. FINAL DX: Severe allergic reaction to flu shot; anxiety; & hyperglycemia.
A report has been received from a Health Professional concerning a 2 year old, Female subject, who had been receiving FLUMIST quadrivalent (intranasal). FLUMIST quadrivalent started on an unknown date. It was reported that patient experienced expired FLUMIST quadrivalent administered to patient (Lot no.-CH2063) which started on 19-Dec-2014. The outcome of the event of expired FLUMIST quadrivalent administered to patient is unknown. The report was considered to be non-serious.
Swelling of face and of hands, shortness of breaths, tachycardia, vomiting.
Moderna COVID-19 Vaccine EUA Extreme back ache (mostly lower right side) Chills
Forehead, bridge of nose, upper lip and cheeks became moderately numb after about 25-30 minutes. The numbness has reduced but is still present approximately 1.5 hours after receiving the injection. I did not seek medical care because the symptoms have decreased.